PROPRIETARY MOLECULAR TECHNOLOGY PLATFORM
A Platform for Advanced Molecular Engineering
Advanced Molecules has developed a proprietary technology platform for the purification, transformation and solid-form engineering of valuable plant-derived and bioactive molecules. Millions have been invested in the research and development behind its know-how and growing intellectual-property portfolio.
Purification
Molecular Engineering
Solid-Form Technology
Co-Crystal Development
PATENT-PENDING TECHNOLOGY
01 — THE PLATFORM
Built as a Platform
THE ADVANCED MOLECULES PLATFORM
One platform. Multiple stages of molecular development.
Advanced Molecules has spent years developing proprietary technology for complex plant-derived and bioactive materials. Rather than a single product or process, the platform is designed to address purification, material consistency, engineered solid forms and improved molecular properties.
Plant-Derived & Bioactive Materials → Advanced Molecules Platform → High-Value Molecular Applications
PLATFORM CAPABILITIES
Purification, material control, solid-form engineering and co-crystal development.
Individual technologies are capabilities within one growing platform of proprietary molecular know-how and intellectual property.
Plant-derived & bioactive materials
Advanced Molecules Platform
High-value applications
02 — RESEARCH & DEVELOPMENT
Multi-Million Strategic Investment in Molecular Innovation
Advanced Molecules is the result of significant investment in scientific research, process development and molecular engineering. Millions have been invested in developing the platform, building proprietary know-how, conducting experimental programmes and creating the foundations of a defensible intellectual-property portfolio.
Scientific Research
Advanced Molecules R&D Platform
Defensible Molecular IP
Purification
Process Development
Material Consistency
Solid-State Science
Molecular Engineering · Co-Crystal Development · Intellectual Property
05 — INTELLECTUAL PROPERTY
Building Defensible Molecular IP
Advanced Molecules is converting years of scientific development into proprietary technology, process know-how and intellectual property. Our strategy is to build a growing IP portfolio around the platform and its applications across valuable plant-derived and bioactive molecules.
Patent-Pending Technology
Proprietary Processes
Solid-Form IP
Process Know-How · Future Molecular Applications
04 — SOLID-FORM & CO-CRYSTAL TECHNOLOGY
Engineering Molecular Performance
The physical form of a molecule can significantly influence performance. Advanced Molecules is developing proprietary solid-form technologies, including co-crystals, designed to modify commercially important physical properties of established molecules.
Molecule + Co-former → Engineered Solid Form → Enhanced Physical Properties
03 — PURIFICATION & MATERIAL CONTROL
From Complex Materials to Consistent Molecular Outputs
Plant-derived materials can present significant challenges in purity, consistency and physical characteristics. Advanced Molecules is developing proprietary processes within its platform to control these variables and transform complex starting materials into consistent, high-quality molecular outputs.
Advanced Purification
Process Control
Material Consistency
Repeatability
Scalability
07 — THE TEAM
Exceptional People Behind the Platform
Advanced Molecules brings together entrepreneurs, technology executives and pharmaceutical scientists with deep experience building companies, developing complex technologies and translating science into commercial applications.
FOUNDERS
Eoin Long
Co-Founder
Technology entrepreneur and founder of EclimAi, where he has led patented AI technology from development to commercialisation. Brings a focus on innovation, IP, strategy and bringing new technologies to market.
James Norton
Co-Founder
Co-founder contributing to Advanced Molecules’ financial, corporate and commercial strategy, with a focus on developing and commercialising the company’s technology and IP portfolio.
Barry Napier
Co-Founder
Technology entrepreneur and Ex-CEO of Cubic Telecom. Brings deep experience in entrepreneurship, corporate strategy, investment and building businesses for global markets.
ADVISORS
Chris Cassapakis
Advisor
International business and corporate development executive with experience across strategic planning, global operations, finance, partnerships and M&A. Brings expertise in structuring partnerships and commercialising technology.
Rory Guinan
Advisor
20+ years of experience in private market investing while working with some of Ireland’s most successful families and entrepreneurs. Brings expertise in company building, investment, strategic development and international growth.
Dr. Anthony Bolton
Advisor
Senior technology and business executive with 35+ years leading global technology transformation. Brings expertise in technology strategy, AI, governance and scaling complex innovation.
SCIENTIFIC ADVISORY BOARD
Dr. Mark Barrett
Scientific Advisor
Co-founder and CEO of APC and VLE Therapeutics, and a chemical engineer and crystallisation researcher. Brings deep expertise in pharmaceutical process development and translating molecular science towards commercial manufacture.
Claudia Bicho-Duarte
Scientific / Pharmaceutical Advisor
Experienced pharmaceutical and regulatory professional with expertise in regulatory affairs, healthcare strategy, compliance and health-authority engagement. Brings valuable perspective on pharmaceutical innovation pathways.
Dr. Brian Glennon
Scientific Advisor
Co-Founder of APC and Emeritus Full Professor at University College Dublin’s School of Chemical and Bioprocess Engineering, with a background in chemical engineering and pharmaceutical industry experience.
06 — COMMERCIAL OPPORTUNITY
One Platform. Multiple Applications.
Technology Licensing
Strategic Partnerships
Joint Development
Molecular Development
IP Commercialisation
ADVANCED MOLECULES PLATFORM
Building a Platform for Better Molecules
Advanced Molecules is building proprietary technology and intellectual property around the purification, transformation and engineering of valuable plant-derived and bioactive molecules.
Platform + Know-How + IP + People